Cravath Swaine & Moore is representing Viatris in the transaction. Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Idorsia Ltd (SIX: IDIA) announced they have entered...
Viatris’ Global Research and Development Collaboration with Idorsia
DRI Healthcare Trust’s Expansion of its Royalty Entitlement on the U.S. Net Sales of Omidria
Cravath Swaine & Moore represented DRI Healthcare Trust in the deal. DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”), a global leader in providing financing to advance...
TowerBrook Capital Partners’ Acquisition of IT Solutions Provider CBTS
Sidley Austin LLP represented TowerBrook Capital Partners L.P. on the transaction, and Cravath Swaine & Moore represented altafiber. TowerBrook Capital Partners (“TowerBrook”) annoubnced the acquisition of...
Montana Technologies’ Joint Venture with GE Vernova
Cravath Swaine & Moore represented Montana Technologies in the deal. Montana Technologies LLC (“Montana Technologies” or “Montana”) announced it agreed to form a joint venture with GE...
CRH plc’s $2.1 Billion Acquisition of Martin Marietta’s South Texas Cement Business
Cravath Swaine & Moore is representing Martin Marietta in the transaction. Martin Marietta Materials, Inc. (NYSE: MLM) (“Martin Marietta”) announced it has entered into a definitive...
White Mountains’ $285 Million Acquisition of a Majority Stake in Bamboo
Cravath, Swaine & Moore is advising White Mountains Insurance Group, Ltd. on the transaction, and Willkie Farr & Gallagher is advising Bamboo and selling equityholders. White...
Thermo Fisher’s Acquisition of Olink
Vinge and Cravath Swaine & Moore advised Thermo Fisher Scientific Inc. on the deal, Ropes & Gray advised Summa Equity AB, Baker McKenzie advised Olink, Debevoise...
Radius Pharmaceuticals’ Royalty Purchase Agreement with DRI Healthcare
Ropes & Gray and Kirkland & Ellis acted as legal advisors to Radius. Cravath, Swaine & Moore acted as legal advisor to DRI Healthcare. Radius Pharmaceuticals,...
Proximus’ Acquisition of a Majority Stake in Route Mobile
Cravath, alongside Slaughter and May, AZB & Partners and NautaDutilh, is representing Route Mobile and its founding shareholders in connection with the transaction. On July 17,...
IBM’s Acquisition of Polar Security
Cravath represented IBM in connection with the transaction. IBM announced it has acquired Polar Security, an innovator in technology that helps companies discover, continuously monitor and...
Viatris’ Acquisition of Famy Life Sciences
Cravath represented Viatris in the transaction, while White & Case advised Famy Life Sciences. Famy Life Sciences, a market-leading drug development platform, announced its entry into...
Viatris’ Acquisition of Oyster Point Pharma
Cooley advised Oyster Point Pharma on the deal, while Cravath represented Viatris. Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, announced its definitive agreement to be acquired...